Warning! GuruFocus detected
1 Severe warning sign
with IMVT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Immunovant Inc
NAICS : 325199
SIC : 2834
ISIN : US45258J1025
Description
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16290.65 | |||||
| Equity-to-Asset | 0.84 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.7 | |||||
| 3-Year EPS without NRI Growth Rate | -14 | |||||
| 3-Year FCF Growth Rate | -17.7 | |||||
| 3-Year Book Growth Rate | 2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -20.53 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.29 | |||||
| 9-Day RSI | 33.1 | |||||
| 14-Day RSI | 34.99 | |||||
| 3-1 Month Momentum % | -25.68 | |||||
| 6-1 Month Momentum % | -37.02 | |||||
| 12-1 Month Momentum % | -40.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.04 | |||||
| Quick Ratio | 6.04 | |||||
| Cash Ratio | 5.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.1 | |||||
| Shareholder Yield % | 0.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -72.39 | |||||
| ROA % | -65.89 | |||||
| ROIC % | -3213.2 | |||||
| 3-Year ROIIC % | -2123.79 | |||||
| ROC (Joel Greenblatt) % | -59835.35 | |||||
| ROCE % | -76.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.14 | |||||
| Price-to-Tangible-Book | 6.14 | |||||
| EV-to-EBIT | -5.67 | |||||
| EV-to-Forward-EBIT | -6.22 | |||||
| EV-to-EBITDA | -5.67 | |||||
| EV-to-Forward-EBITDA | -6.22 | |||||
| EV-to-FCF | -7.41 | |||||
| Price-to-Net-Current-Asset-Value | 6.32 | |||||
| Price-to-Net-Cash | 7.11 | |||||
| Earnings Yield (Greenblatt) % | -17.64 | |||||
| FCF Yield % | -13.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMVT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunovant Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.62 | ||
| Beta | 0.66 | ||
| 3-Year Sharpe Ratio | 0.79 | ||
| 3-Year Sortino Ratio | 2.59 | ||
| Volatility % | 30.63 | ||
| 14-Day RSI | 34.99 | ||
| 14-Day ATR ($) | 1.286237 | ||
| 20-Day SMA ($) | 18.578 | ||
| 12-1 Month Momentum % | -40.86 | ||
| 52-Week Range ($) | 14.34 - 34.47 | ||
| Shares Outstanding (Mil) | 169.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immunovant Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immunovant Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immunovant Inc Frequently Asked Questions
What is Immunovant Inc(IMVT)'s stock price today?
The current price of IMVT is $14.73. The 52 week high of IMVT is $34.47 and 52 week low is $14.34.
When is next earnings date of Immunovant Inc(IMVT)?
The next earnings date of Immunovant Inc(IMVT) is 2025-05-29 Est..
Does Immunovant Inc(IMVT) pay dividends? If so, how much?
Immunovant Inc(IMVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers